Hanmei Xu Selected Research

Antisense Oligonucleotides

1/2020

Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanmei Xu Research Topics

Disease

35	Neoplasms (Cancer) 05/2024 - 07/2011
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Carcinogenesis 10/2022 - 01/2018
3	Infections 01/2021 - 07/2012
3	Inflammation (Inflammations) 01/2020 - 07/2017
3	Rheumatoid Arthritis 04/2019 - 09/2018
2	Kidney Neoplasms (Kidney Cancer) 05/2024 - 01/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 01/2022
2	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 01/2023
2	Pathologic Processes 10/2022 - 09/2021
2	Arthritis (Polyarthritis) 09/2022 - 07/2017
2	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 12/2018
2	Esophageal Squamous Cell Carcinoma 06/2020 - 01/2018
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2020
2	Septic Shock (Toxic Shock Syndrome) 12/2015 - 01/2014
2	Shock 12/2015 - 01/2014
1	Triple Negative Breast Neoplasms 10/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Ankylosing Spondylitis 09/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Insulin Resistance 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Body Weight Changes 10/2020
1	Mouth Neoplasms (Oral Cancer) 08/2020
1	Neuralgia (Stump Neuralgia) 03/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Lung Injury 05/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019

Drug/Important Bio-Agent (IBA)

19	Peptides (Polypeptides)IBA 01/2022 - 01/2014
9	IntegrinsIBA 09/2021 - 09/2015
8	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2016
6	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2017
6	CytokinesIBA 10/2020 - 01/2014
4	RNA (Ribonucleic Acid)IBA 10/2022 - 09/2015
4	Long Noncoding RNAIBA 01/2022 - 01/2018
3	Sunitinib (Sutent)FDA Link 05/2024 - 08/2019
3	Phosphotransferases (Kinase)IBA 01/2024 - 09/2015
3	AntigensIBA 10/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2018
3	MicropeptidesIBA 10/2022 - 01/2020
3	Therapeutic UsesIBA 01/2021 - 01/2016
3	MesothelinIBA 11/2020 - 01/2018
3	MicroRNAs (MicroRNA)IBA 06/2020 - 01/2018
3	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 08/2013
3	Matrix Metalloproteinase InhibitorsIBA 03/2014 - 08/2013
2	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2020
2	Aquaporin 2IBA 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2019
2	CateninsIBA 01/2020 - 01/2018
2	LipidsIBA 01/2020 - 08/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 08/2019
2	Indicators and Reagents (Reagents)IBA 08/2019 - 12/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2019
2	Angiogenesis InhibitorsIBA 01/2019 - 07/2011
2	arginyl-glycyl-aspartic acidIBA 01/2018 - 10/2016
1	atezolizumabIBA 05/2024
1	MitogensIBA 01/2024
1	coumaranIBA 05/2023
1	eudesm-5-en-11-olIBA 05/2023
1	Polo-Like Kinase 1IBA 05/2023
1	piperitoneIBA 05/2023
1	Ethanol (Ethyl Alcohol)IBA 05/2023
1	triptolideIBA 09/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	StreptavidinIBA 01/2022
1	AntibodiesIBA 09/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	ChitosanIBA 01/2021
1	VaccinesIBA 01/2021
1	AutoantibodiesIBA 10/2020
1	Vincristine (Oncovin)FDA LinkGeneric 08/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2020
1	AMP-Activated Protein KinasesIBA 03/2020
1	Immunoglobulin Fc FragmentsIBA 02/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2020
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 02/2020
1	Proto-Oncogene Proteins c-metIBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	Antisense OligonucleotidesIBA 01/2020
1	Integrin beta4IBA 01/2020
1	SeptinsIBA 01/2020
1	salinomycinIBA 01/2020
1	ConnectinIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2019
1	Glycoproteins (Glycoprotein)IBA 04/2019
1	tocophersolanIBA 01/2019

Therapy/Procedure

18	Therapeutics 05/2024 - 07/2012
4	Immunotherapy 01/2019 - 01/2014
2	Intraperitoneal Injections 12/2015 - 01/2014
1	Drug Therapy (Chemotherapy) 01/2023
1	Analgesia 01/2019